The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent
Open Access
- 30 April 2021
- journal article
- research article
- Published by Taylor & Francis in Human Fertility
- Vol. 25 (5) , 881-887
Abstract
The effect of Uterine Fibroid Embolization on fertility and ovarian reserve remains uncertain. We assessed the impact of a new resorbable, spherical particle (Gelbead) on concentration of Anti-Mullerian (AMH) hormone, fibroid volume and uterine artery patency. This prospective cohort study recruited consecutive patients from July 2017 to June 2018. Serum AMH, fibroid and uterine volume, UFS-QOL (uterine fibroid score-quality of life) scores were measured prior to and at 1 month and/or 3 months post embolization. Twenty-four participants were enrolled (median age 44 years, uterine volume 484 cm3, initial dominant fibroid volume 167 cm3). One patient was lost to follow-up. AMH (median ± SD) immediately prior to embolization was 3.2 ± 13.7 pmol/L. At 1-month postembolization, AMH was 4.1 ± 8.6 pmol/L and at 3 months 4.4 ± 8.6 pmol/L. We found no significant difference in AMH levels between baseline and at 1 month (p = 0.58) or baseline and 3 months (p = 0.17). The median dominant uterine fibroid volume decreased (167 to 64 cm3, p < 0.001). At 3 months post-embolization, 17/23 patients had patent uterine arteries bilaterally (73.9%). UFE with Gel-bead did not significantly affect AMH at 3 months post embolization, whilst maintaining a high rate of uterine artery patency.Keywords
This publication has 31 references indexed in Scilit:
- MRI Assessment of Uterine Artery Patency and Fibroid Infarction Rates 6 Months after Uterine Artery Embolization with Nonspherical Polyvinyl AlcoholCardioVascular and Interventional Radiology, 2013
- Stability of AMH measurement in blood and avoidance of proteolytic changesReproductive BioMedicine Online, 2013
- Pregnancy outcomes after uterine artery occlusion: prospective multicentric studyFertility and Sterility, 2008
- Anti-Müllerian hormone and ovarian dysfunctionTrends in Endocrinology & Metabolism, 2008
- Clinical experience and fertility outcome after uterine artery occlusion and embolizationGynecological Surgery, 2007
- Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomyHuman Reproduction, 2007
- Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomyAmerican Journal of Obstetrics and Gynecology, 2004
- Transient ovarian failure: a rare complication of uterine fibroid embolizationActa Obstetricia et Gynecologica Scandinavica, 2004
- Embolic microspheres within ovarian arterial vasculature after uterine artery embolizationObstetrics & Gynecology, 2002
- The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomataObstetrics & Gynecology, 2002